NCT06812195 (osteoporosis) is a NA clinical trial of Plate and nail in Osteopenia, Osteoporosis, sponsored by Assiut University.

Who is sponsoring NCT06812195?

NCT06812195 is sponsored by Assiut University.

What drugs are being tested in NCT06812195?

Interventions in NCT06812195: Plate and nail.

What condition does NCT06812195 study?

NCT06812195 studies Osteopenia, Osteoporosis.

Is NCT06812195 still recruiting?

NCT06812195 is currently not yet recruiting. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT06812195: osteoporosis

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Periprosthetic Plate Over Humeral Nail

Not yet recruiting NA Last updated 12 February 2025

What this trial tests

NA trial testing Plate and nail in Osteopenia, Osteoporosis in 3 participants. Not yet recruiting.

Timeline

1 March 2025

Primary endpoint
1 March 2026

1 March 2026

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	3
Start date	1 March 2025
Primary completion	1 March 2026
Estimated completion	1 March 2026

Drugs / interventions tested

Plate and nail

Conditions studied

Osteopenia, Osteoporosis — all drugs for Osteopenia, Osteoporosis →

Sponsor

Assiut University

Who can join

Adults 16 to 40, any sex, with Osteopenia, Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

use of plate over humeral nail in deformity correction of femur in adult osteoporotic bone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteopenia, Osteoporosis

Currently open trials in the same condition.

NCT06851676 — Functional and Metabolic Effects of Fonte Fausta® Water on Bone and Muscle Health in Osteoporotic Patients · NA · recruiting
NCT06018467 — Senolytics to Improve Osteoporosis Therapy · Phase 2 · active not recruiting
NCT06781541 — Physical Activity and Disability Prevention in Postmenopausal Women · NA · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06812195 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing